[1]Adeniji,AdegokeO.;Twenter,BarryM.;Byrns,MichaelC.;Jin,Yi;Winkler,JeffreyD.;Penning,TrevorM.[BioorganicandMedicinalChemistryLetters,2011,vol.21,#5,p.1464-1468]
[2]Adeniji,AdegokeO.;Twenter,BarryM.;Byrns,MichaelC.;Jin,Yi;Chen,Mo;Winkler,JeffreyD.;Penning,TrevorM.[JournalofMedicinalChemistry,2012,vol.55,#5,p.2311-2323]
[1]Adeniji,AdegokeO.;Twenter,BarryM.;Byrns,MichaelC.;Jin,Yi;Winkler,JeffreyD.;Penning,TrevorM.[BioorganicandMedicinalChemistryLetters,2011,vol.21,#5,p.1464-1468]
[2]Adeniji,AdegokeO.;Twenter,BarryM.;Byrns,MichaelC.;Jin,Yi;Chen,Mo;Winkler,JeffreyD.;Penning,TrevorM.[JournalofMedicinalChemistry,2012,vol.55,#5,p.2311-2323]
Title: Adegoke O Adeniji, et al. Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships. J Med Chem. 2012 Mar 8;55(5):2311-23.